High Quality Content by WIKIPEDIA articles! Michael Hayden, MB ChB PhD FRCP(C) FRSC OBC CM (born November 21, 1951) is a Canadian physician scientist. A Killam professor of Medical Genetics at the University of British Columbia and Canada Research Chair in Human Genetics and Molecular Medicine, Hayden is best known for his research in Huntington disease (HD). He is also the founder and director of the Centre for Molecular Medicine and Therapeutics, part of UBC’s Faculty of Medicine and affiliated with the Child & Family Research Institute and the BC Children’s Hospital Foundation. Hayden is the most cited author in the world for HD and ABCA1. In 2010 he was awarded the Order of Canada, following his receipt of the Order of British Columbia in 2009. Hayden received the Canada Gairdner Foundation Wightman Award in 2011, and in 2009 was named Canada’s Health Researcher of the Year and received the CIHR Michael Smith Prize in Health Research - Biomedical and Clinical Research. In addition to his academic work, Hayden is also the founder of three biotechnology companies, NeuroVir, Xenon Genetics Inc. and Aspreva Pharmaceuticals. He is the Chief Scientific Director of Xenon.